GlassScriptPhysician profile
Jason M Hebert
NPI 1033110226
$1,554.40
in general payments reported to CMS, 2019-2025
19 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $304 · 2022: $342 · 2023: $588 · 2024: $192 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $292.36 | 2022-2024 | Farxiga |
| Esperion Therapeutics, INC. | $232.82 | 2021-2025 | Nexletol |
| Pfizer INC. | $213.21 | 2021-2025 | |
| Cvrx, INC. | $107.00 | 2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $103.55 | 2021-2024 | Camzyos, Eliquis |
| Boston Scientific Corporation | $102.76 | 2022 | |
| Amgen INC. | $95.74 | 2021-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $92.14 | 2021-2024 | |
| Medtronic, INC. | $63.10 | 2022-2023 | Evera Mri Xt Dr Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.41 | 2023-2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $41.89 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $29.45 | 2021 | |
| Kestra Medical Technology Services, INC. | $28.13 | 2025 | Assure Wcd |
| Abbott Laboratories | $24.15 | 2025 | Cardiomems |
| Alnylam Pharmaceuticals INC. | $23.59 | 2023 | Onpattro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.47 | 2024 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $16.45 | 2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $15.96 | 2023 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.22 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.